Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS)- An integrated analysis of the phase 3 define and confirm studies
May 1, 2013, 00:00
10.1016/j.jval.2013.03.481
https://www.valueinhealthjournal.com/article/S1098-3015(13)00552-4/fulltext
Title :
Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS)- An integrated analysis of the phase 3 define and confirm studies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00552-4&doi=10.1016/j.jval.2013.03.481
First page :
A102
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
23